Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Luminex Corp (NASDAQ:LMNX)

21.87
Delayed Data
As of 11:46am ET
 -0.23 / -1.04%
Today’s Change
17.68
Today|||52-Week Range
22.42
+8.11%
Year-to-Date
Five Scorching Hot Strong Buy Stocks
Nov 21 / Zacks.com - Paid Partner Content
QIAGEN (QGEN) Faces Declining HPV Sales, Intense Competition
Nov 10 / Zacks.com - Paid Partner Content
Medtronic (MDT) Beats on Q2 Earnings, Reiterates FY18 View
Nov 21 / Zacks.com - Paid Partner Content
TransEnterix (TRXC) Posts In-Line Loss in Q3, Sales Fall Y/Y
Nov 10 / Zacks.com - Paid Partner Content
Patterson Companies (PDCO) Misses on Q2 Earnings, Cuts View
Nov 21 / Zacks.com - Paid Partner Content
Dull MFA & Mineral Nutrition Sales Hurt Phirbo, Rivalry Rife
Nov 09 / Zacks.com - Paid Partner Content
Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength
Nov 16 / Zacks.com - Paid Partner Content
Hologic (HOLX) Q4 Earnings & Revenues Top, Margins Down
Nov 09 / Zacks.com - Paid Partner Content
Here's Why Investors Should Buy Myriad Genetics Right Now
Nov 16 / Zacks.com - Paid Partner Content
Genomic Health (GHDX) Swings to Earnings in Q3, Revenues Lag
Nov 09 / Zacks.com - Paid Partner Content
Myriad Genetics' Latest Alliance to Boost GeneSight Reach
Nov 15 / Zacks.com - Paid Partner Content
Hill-Rom (HRC) Banks on Product Launches, Competition Rife
Nov 09 / Zacks.com - Paid Partner Content
DaVita Issues Downbeat '17 View, Hurricanes Affect Q3 Results
Nov 15 / Zacks.com - Paid Partner Content
Amedisys (AMED) Q3 Earnings Beat, Revenues Miss Estimates
Nov 09 / Zacks.com - Paid Partner Content
Here's Why Investors Should Buy Luminex (LMNX) Right Now
Nov 15 / Zacks.com - Paid Partner Content
Globus Medical (GMED) Q3 Earnings In Line, View Reiterated
Nov 09 / Zacks.com - Paid Partner Content
Quest Diagnostics, Clinical Genomics Ally, Oncology Strong
Nov 14 / Zacks.com - Paid Partner Content
Baxter Posts Solid Q3, Broad Product Spectrum Raises Hopes
Nov 09 / Zacks.com - Paid Partner Content
Weight Watchers (WTW) to Issue $500M Senior Notes Due 2025
Nov 14 / Zacks.com - Paid Partner Content
SurModics (SRDX) Posts Earnings in Q4, Revenues Top Estimates
Nov 09 / Zacks.com - Paid Partner Content
Medtronic Preliminary Sales Dip Y/Y, Hurricane Blow Lessens
Nov 13 / Zacks.com - Paid Partner Content
Penumbra (PEN) Posts Earnings, Revenues Top Estimates in Q3
Nov 08 / Zacks.com - Paid Partner Content
Bio-Rad (BIO) Beats Earnings and Revenue Estimates in Q3
Nov 13 / Zacks.com - Paid Partner Content
VWR Q3 Earnings Top, Sell-Off to Avantor Approaching Closure
Nov 08 / Zacks.com - Paid Partner Content
BioTelemetry (BEAT) Q3 Earnings Miss, Revenues Meet Estimates
Nov 13 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Q2 Earnings Beat Estimates, EPS View Up
Nov 08 / Zacks.com - Paid Partner Content
Bruker's NANO Grows Strong, MERLIN Buyout Holds Promise
Nov 10 / Zacks.com - Paid Partner Content
DaVita (DVA) Q3 Earnings Miss & Revenues Beat, '17 View Dull
Nov 08 / Zacks.com - Paid Partner Content
Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session
Nov 10 / Zacks.com - Paid Partner Content
Myriad Genetics (MYGN) Beats on Q1 Earnings & Revenues
Nov 08 / Zacks.com - Paid Partner Content
AmerisourceBergen (ABC) Rewards Investors With Dividend Hike
Nov 10 / Zacks.com - Paid Partner Content
Align Technology at 52-Week High: What's Driving the Stock?
Nov 08 / Zacks.com - Paid Partner Content
OPKO Health (OPK) Posts Wider-Than-Estimated Loss in Q3
Nov 10 / Zacks.com - Paid Partner Content
Inogen (INGN) Beats Earnings and Revenue Estimates in Q3
Nov 08 / Zacks.com - Paid Partner Content
Inogen Claims Top Position in Deloitte List on Solid Growth
Nov 10 / Zacks.com - Paid Partner Content